InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
14%
T+90 mean return
-16.3%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Lanfear Dennis M, Chairman & CEO. Insider active across 1 company, notably Coherus BioSciences, Inc.. Aggregated, 14 reports have been recorded. History available since 6 June 2021. The latest transaction was disclosed on 20 January 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
11,810 shares@ US$1.393.5% of flowCommon StockSEC:0001610717-25-000013:0
11,810 shares@ US$1.664.2% of flowCommon StockSEC:0001610717-25-000009:0
11,218 shares@ US$2.445.6% of flowCommon StockSEC:0001610717-24-000039:0
11,781 shares@ US$2.927.0% of flowCommon StockSEC:0001610717-24-000019:0
41,000 shares@ US$1.41711.8% of flowCommon StockSEC:0001610717-23-000363:0
86,250 shares0Common StockSEC:0001567619-23-001211:0
10,905 shares@ US$9.8722.6% of flowCommon StockSEC:0001567619-23-000698:0
4,000 shares0Common StockSEC:0001567619-23-000350:0
86,250 shares0Common StockSEC:0001567619-22-000821
86,250 shares0Common StockSEC:0001567619-22-000821:0
10,000 shares0Common StockSEC:0001567619-21-021059:0
10,000 shares0Common StockSEC:0001567619-21-021059
300,000 shares@ US$0.41680.060% mcap50.0% of flowCommon StockSEC:0001567619-21-011842:0
300,000 shares@ US$0.416822.7% of flowCommon StockSEC:0001567619-21-011842
14 of 14 declarations
About Lanfear Dennis M
Dennis M. Lanfear is the President and CEO of Coherus BioSciences, Inc. He leads the company in the development of innovative biopharmaceutical solutions. His role involves guiding the overall strategy of Coherus, with a focus on innovation and research. Dennis is responsible for managing operations and driving the company's growth in the biopharmaceutical market.
